Partners and Collaborators
Government
Centers for Disease Control and Prevention (CDC), part of the U.S. Department of Health and Human Services, CDC focuses on protecting and improving the public health through health promotion, prevention of disease, injury and disability, and preparing for new health threats.
Office of the U.S. Global AIDS Coordinator, part of the U.S. Department of State, leads the U.S. President's Emergency Plan for AIDS Relief (PEPFAR). Launched in 2003 by President Bush, PEPFAR aims to combat global HIV/AIDS.
U.S. Agency for International Development (USAID) supports long-term and equitable economic growth internationally by promoting agriculture and trade; global health; democratic principles, conflict prevention and humanitarian assistance.
U.S. Military HIV Research Program (USMHRP) was established in 1985 to protect U.S.troops entering endemic HIV areas and is dedicated to HIV vaccine development, prevention, disease surveillance, and HIV care and treatment. NIAID plans and executes HIV/AIDS research projects with the USMHRP through an interagency agreement.
Non-Government
Alliance for Microbicide Development, founded in 1998, is a nonprofit, multidisciplinary, advocacy organization focused on speeding the development of microbicides to prevent HIV and other sexually transmitted infections.
The Bill & Melinda Gates Foundation is a non-profit organization created in 2000 to help people lead healthy, productive lives. In developing countries, the foundation focuses on improving health and ending hunger and extreme poverty.
Center for HIV/AIDS Vaccine Immunology (CHAVI), which was established by NIAID as part of the Global HIV/AIDS Vaccine Enterprise, is designed to answer basic science questions relevant to HIV vaccines and to conduct early phase HIV vaccine clinical trials at clinical sites around the world.
Contraceptive Research and Development (CONRAD) is focused on facilitating the rapid development of safe, acceptable, affordable products and methods that provide contraception and/or prevent the sexual transmission of HIV/AIDS and other infections.
Global HIV Vaccine Enterprise (GHAVE) is a consortium of organizations committed to the development of a preventive HIV vaccine by implementing shared scientific plans, mobilizing resources, and improving international collaborations.
International AIDS Vaccine Initiative (IAVI), which was founded in 1996 to speed discovery of an HIV vaccine, partners with private companies, academic institutions, and government agencies, including the NIH.
International Partnership for Microbicides (IPM) is a non-profit product development partnership established in 2002 to accelerate the development and availability of a safe and effective microbicide to prevent HIV infection among women in developing countries.
Partnership for AIDS Vaccine Evaluation (PAVE) is a voluntary consortium of U.S. government agencies and U.S. government-funded organizations involved in HIV vaccine research. PAVE members include: NIAID, the NIH Office of AIDS Research, the NIAID-funded HIV Vaccine Trials Network, the U.S. Agency for International Development, the U.S. Military HIV Research Program, the Centers for Disease Control and Prevention, and the International AIDS Vaccine Initiative.
The United Nations Joint Programme on HIV/AIDS (UNAIDS), orchestrates the efforts and resources of 10 U.N. system organizations to help prevent new HIV infections, care for people living with HIV, and mitigate the impact of the epidemic. As part of the United Nations, the UNAIDS works with the World Health Organization to determine how results obtained from NIAID research studies should be applied around the world.
The World Health Organization (WHO) is responsible for providing leadership on global health matters, shaping the health research agenda, setting norms and standards, articulating evidence-based policy options, providing technical support to countries, and monitoring and assessing health trends. Based on results from NIH studies, the WHO and UNAIDS guide health ministries and aid organizations in determining how research findings should be applied to the provision of health services in different parts of the world.
back to top